93 related articles for article (PubMed ID: 18714163)
1. Prolongation of survival and improvement in performance status following palliative chemotherapy in gastrointestinal cancer patients with a poor performance status.
Shitara K; Munakata M; Kasai M; Muto O; Sakata Y
Oncology; 2008; 74(3-4):135-42. PubMed ID: 18714163
[TBL] [Abstract][Full Text] [Related]
2. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
Shuch B; La Rochelle JC; Wu J; Klatte T; Riggs SB; Kabbinavar F; Belldegrun AS; Pantuck AJ
Cancer; 2008 Sep; 113(6):1324-31. PubMed ID: 18661529
[TBL] [Abstract][Full Text] [Related]
3. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
4. Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.
Kim YH; Goto K; Yoh K; Niho S; Ohmatsu H; Kubota K; Saijo N; Nishiwaki Y
Cancer; 2008 Nov; 113(9):2518-23. PubMed ID: 18780323
[TBL] [Abstract][Full Text] [Related]
5. The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy.
Persson C; Glimelius B
Anticancer Res; 2002; 22(6B):3661-8. PubMed ID: 12552973
[TBL] [Abstract][Full Text] [Related]
6. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
Chamberlain MC; Johnston SK; Glantz MJ
Arch Neurol; 2009 Jan; 66(1):74-8. PubMed ID: 19139302
[TBL] [Abstract][Full Text] [Related]
7. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
[TBL] [Abstract][Full Text] [Related]
8. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
Inoue A; Kobayashi K; Usui K; Maemondo M; Okinaga S; Mikami I; Ando M; Yamazaki K; Saijo Y; Gemma A; Miyazawa H; Tanaka T; Ikebuchi K; Nukiwa T; Morita S; Hagiwara K;
J Clin Oncol; 2009 Mar; 27(9):1394-400. PubMed ID: 19224850
[TBL] [Abstract][Full Text] [Related]
9. [Palliative chemotherapy in metastatic and locally advanced gastrointestinal tumor].
Dippold W
Zentralbl Chir; 1998; 123(6):722-4. PubMed ID: 9703647
[TBL] [Abstract][Full Text] [Related]
10. Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Pectasides D; Papaxoinis G; Fountzilas G; Aravantinos G; Bamias A; Pavlidis N; Kalofonos HP; Timotheadou E; Samantas E; Briasoulis E; Skarlos DV; Economopoulos T; Dimopoulos MA;
Anticancer Res; 2009 Feb; 29(2):745-51. PubMed ID: 19331231
[TBL] [Abstract][Full Text] [Related]
11. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction.
Wang Z; Chen K; Gong J; Zheng Y; Wang T
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831
[TBL] [Abstract][Full Text] [Related]
12. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
14. CD4CD25+ regulatory T cells in patients with advanced gastrointestinal cancer treated with chemotherapy.
Xu H; Mao Y; Dai Y; Wang Q; Zhang X
Onkologie; 2009 May; 32(5):246-52. PubMed ID: 19420970
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
16. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome.
Hong SH; Koh YH; Rho SY; Byun JH; Oh ST; Im KW; Kim EK; Chang SK
Jpn J Clin Oncol; 2009 Jan; 39(1):54-61. PubMed ID: 18997182
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pleural fluid data in patients with malignant effusion.
Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
19. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
